What happened to Dr. Kogelnik?

[Navid]

Does anyone know what he is doing these days?

 

[wigglethemouse]

He still runs his clinic which also has a lab draw station. Looks like there is one other doctor (nutritionist) working with him.
http://www.openmedicineinstitute.org/the-clinic.html

The Open Medicine Clinic is a leader in practicing precision medicine in the era of big data. Our physicians and other providers offer clinical services in the following areas:

• Unexplained/Difficult Cases
• Genomic Medicine
• General Internal Medicine
• Infectious Diseases and HIV
• Diet and Nutrition Consultation
• Immunology

We are a fee-for-service clinic adjacent to the Open Medicine Institute. On site services include:

• IV Infusion services
• Stress/VO2 max testing (via OMI)
• Lab draw services (via OMI)
• SIBO testing, and more

We see adult and pediatric patients.

Andreas Kogelnik, MD, PhD

Andreas Kogelnik, MD, PhD, is the Director of the Institute. He completed his MD at Emory University School of Medicine and his PhD in Bioengineering at Georgia Tech. He trained as a resident in Internal Medicine and fellow in Infectious Diseases at Stanford University and remained there as a post-doc and research faculty before founding the Clinic in 2009 and Institute in 2011.

 

[wigglethemouse]

He also has an ME-pedia entry.
https://me-pedia.org/wiki/Andreas_Kogelnik

 

[Diwi9]

For some reason I thought he's participating in the Cortene trial. I might be wrong and someone should correct me, if I am!

 

[wigglethemouse]

For some reason I thought he's participating in the Cortene trial. I might be wrong and someone should correct me, if I am!

It's the Bateman Horne clinic that is participating in the Cortene trial. A participant has a blog that is linked in this post
https://forums.phoenixrising.me/threads/cortene-trial.62213/post-1012178

Official clinical trial details that confirm Bateman Horne
https://clinicaltrials.gov/ct2/show/NCT03613129

 

[Diwi9]

@wigglethemouse - Interesting because I thought Kogelnik split with Kaufman/Chheda at the same time this trial began because of divided focus on a clinical trial vs. patient treatment. Anyone know more?